Barclays PLC Boosts Stake in Viemed Healthcare, Inc. (NASDAQ:VMD)

Barclays PLC raised its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 342.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 53,439 shares of the company’s stock after acquiring an additional 41,358 shares during the period. Barclays PLC owned approximately 0.14% of Viemed Healthcare worth $392,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. National Bank of Canada FI increased its stake in Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after acquiring an additional 1,596 shares during the last quarter. Wasatch Advisors LP raised its holdings in shares of Viemed Healthcare by 19.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after buying an additional 303,277 shares during the period. Raffles Associates LP lifted its stake in Viemed Healthcare by 11.0% during the 3rd quarter. Raffles Associates LP now owns 402,691 shares of the company’s stock worth $2,952,000 after acquiring an additional 40,000 shares in the last quarter. PDT Partners LLC purchased a new position in Viemed Healthcare during the 3rd quarter valued at about $78,000. Finally, Walleye Capital LLC acquired a new position in Viemed Healthcare in the 3rd quarter valued at about $87,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Trading Down 0.1 %

Shares of VMD stock opened at $8.12 on Friday. Viemed Healthcare, Inc. has a fifty-two week low of $6.21 and a fifty-two week high of $10.44. The company has a 50 day moving average price of $8.60 and a 200 day moving average price of $7.82. The stock has a market capitalization of $316.17 million, a P/E ratio of 30.07 and a beta of 1.46. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The company had revenue of $58.00 million for the quarter.

Insider Activity at Viemed Healthcare

In other news, Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the transaction, the director now owns 126,843 shares in the company, valued at approximately $1,212,619.08. This represents a 19.13 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now owns 107,706 shares in the company, valued at $999,511.68. This represents a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 72,256 shares of company stock valued at $674,739 over the last quarter. 20.00% of the stock is owned by insiders.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.